GlassScriptPhysician profile
Jared Matthew Criddle
NPI 1235364803
$7,983.41
in general payments reported to CMS, 2019-2025
45 companies · $686 in 2025
The $686 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $309 · 2021: $1,304 · 2022: $2,962 · 2023: $721 · 2024: $1,068 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459 · Education: $16.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,458.94 |
| Education | $16.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,901.89 | 2021-2025 | Abre |
| Angiodynamics, INC. | $985.57 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $777.38 | 2019-2022 | |
| Medtronic USA, INC. | $772.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $579.05 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $307.20 | 2021-2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $246.51 | 2021-2025 | Farxiga, Lokelma, Brilinta |
| Travere Therapeutics, INC. | $223.45 | 2022-2025 | |
| Amgen INC. | $195.85 | 2021-2025 | Tavneos, Parsabiv, Krystexxa |
| Vifor Pharma, INC. | $193.88 | 2021-2024 | Veltassa |
| Bard Peripheral Vascular, INC. | $178.86 | 2021-2025 | Pristine, Covera, Venclose Maven Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $159.64 | 2022-2025 | |
| Cumberland Pharmaceuticals, INC. | $143.73 | 2021 | |
| Aurinia Pharma U.S., INC. | $127.98 | 2021-2024 | Lupkynis |
| Philips North America LLC | $122.87 | 2021-2024 | (Br5) Peripheral Ivus |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $85.41 | 2021-2025 | Supera, Diamondback Peripheral |
| Ardelyx, INC. | $85.41 | 2024-2025 | Ibsrela |
| Calliditas Therapeutics US INC. | $83.17 | 2022-2025 | Tarpeyo |
| Opko Pharmaceuticals, LLC | $73.89 | 2021-2023 | Rayaldee |
| Mallinckrodt Hospital Products INC. | $65.63 | 2021-2023 | Acthar |
| Terumo Medical Corporation | $62.40 | 2019 | |
| Akebia Therapeutics INC | $60.57 | 2023-2024 | Auryxia, Vafseo |
| Lilly USA, LLC | $56.37 | 2024-2025 | Jardiance |
| Reflow Medical INC | $43.40 | 2025 | |
| Glaxosmithkline, LLC. | $42.38 | 2024 | Benlysta, Jesduvroq |
| Ani Pharmaceuticals, INC. | $40.12 | 2024-2025 | Purified Cortrophin Gel |
| Nevro Corp. | $37.79 | 2024 | Senza |
| Veloxis Pharmaceuticals, INC. | $33.70 | 2023 | Envarsus |
| Otsuka America Pharmaceutical, INC. | $29.72 | 2022 | |
| Novo Nordisk INC | $27.34 | 2021-2025 | Wegovy |
| Vbi Vaccine (Delaware) INC. | $21.39 | 2022 | |
| Kyowa Kirin, INC. | $20.28 | 2023 | |
| Argenx US, INC. | $20.27 | 2023 | Vyvgart Hytrulo |
| Becton, Dickinson and Company | $18.35 | 2024 | Covera |
| W. L. Gore & Associates, INC. | $18.00 | 2025 | Gore Viabahn Endoprosthesis |
| Cardiva Medical, INC. | $17.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.19 | 2023 | Jardiance |
| Scpharmaceuticals INC. | $15.98 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.28 | 2023 | Gattex |
| Horizon Therapeutics Plc | $14.42 | 2023 | Krystexxa |
| Cormedix INC. | $13.99 | 2024 | Defencath |
| Argon Medical Devices, INC. | $13.63 | 2023 | Cleaner |
| Merck Sharp & Dohme LLC | $13.58 | 2024 | Prevymis |
| Daiichi Sankyo INC. | $12.97 | 2022 | |
| Cms Imaging, INC. | $8.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Criddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.